Toru Nishiyama
Papers
2
Total Citations
9
H-Index
2
About
Toru Nishiyama is a urologic surgeon and researcher whose work focuses on the frontiers of salvage therapy for recurrent prostate cancer. His primary research areas include robotic-assisted radical prostatectomy (RARP) and the management of patients who have failed initial definitive radiotherapy. Nishiyama’s major contributions lie in demonstrating the feasibility and safety of salvage RARP following novel primary treatments, such as heavy ion radiotherapy (HIRT). His 2016 case report, the first of its kind, documented a successful salvage RARP after HIRT, opening a new surgical pathway for patients with limited options. He has also systematically compared outcomes of whole-gland salvage treatments, including brachytherapy and RARP, in a case series of patients with locally recurrent disease. While his citation counts (5 and 4 for his key papers) reflect a niche but clinically critical area, his work is highly influential among specialists in radiation oncology and urologic surgery. Nishiyama’s research directly addresses the growing challenge of managing prostate cancer recurrence, providing evidence-based guidance for complex, high-stakes salvage procedures.
Research Focus
Key Achievements
Top Papers
- 1
- 2